Crescent Biopharma, Inc. (CBIO)

Crescent Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024
Period Ending	Dec 15, 2025	Dec 31, 2024
Debt / Equity Ratio	-3.26	-3.26
Quick Ratio	3.62	3.62
Current Ratio	3.62	3.62
Return on Capital Employed (ROCE)	-264.40%	-264.40%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q